Raymond James Financial Services Advisors’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$4.75K Hold
1,813
﹤0.01% 3434
2024
Q2
$6.38K Hold
1,813
﹤0.01% 3384
2024
Q1
$12.1K Hold
1,813
﹤0.01% 3361
2023
Q4
$18.1K Sell
1,813
-378
-17% -$2.86K ﹤0.01% 3240
2023
Q3
$15.1K Hold
2,191
﹤0.01% 3206
2023
Q2
$23.8K Hold
2,191
﹤0.01% 3167
2023
Q1
$32.8K Sell
2,191
-233
-10% -$5.02K ﹤0.01% 3153
2022
Q4
$65K Sell
2,424
-63
-3% -$1.81K ﹤0.01% 3061
2022
Q3
$78K Buy
2,487
+218
+10% +$5.65K ﹤0.01% 3034
2022
Q2
$52K Buy
2,269
+561
+33% +$16K ﹤0.01% 3084
2022
Q1
$61K Hold
1,708
﹤0.01% 3172
2021
Q4
$53K Buy
+1,708
New +$65.8K ﹤0.01% 3181

Other funds holding BMRA

Raymond James Financial Services Advisors's BMRA Position: Q3 2024 in Review

Raymond James Financial Services Advisors held its Biomerica (BMRA) position steady in Q3 2024 at 1,813 shares worth $4.75K. The position accounts for ﹤0.01% of the portfolio, ranked #3434.

Raymond James Financial Services Advisors first reported a position in BMRA in Q4 2021 and has held it in 12 quarters since. The position peaked at $78K in Q3 2022. 25 funds tracked by Wall St. Rank hold BMRA as of Q3 2024.

  • Raymond James Financial Services Advisors held 1,813 shares of Biomerica worth $4.75K as of Q3 2024.
  • Raymond James Financial Services Advisors left its Biomerica share count unchanged in Q3 2024.
  • Biomerica made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3434 holding.
  • Raymond James Financial Services Advisors first reported a position in Biomerica in Q4 2021 and has held it in 12 quarters since.
  • Raymond James Financial Services Advisors's Biomerica position peaked at $78K in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Biomerica as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.